Enlivex Shares Rise Slightly While Market Cap Remains Low
Enlivex Therapeutics Ltd. (ticker ENLV) closed the trading session on Wednesday, 21 January 2026 at a price of USD 0.22 per share, reflecting a 0.98 % increase from the previous close. The stock was last traded at 12:58 AM Central Europe.
Trading Metrics
- Shares Outstanding: 19.9 million
- Market Capitalisation: USD 4.1 million
- Volume (24 h): USD 125.5 k of shares exchanged
- 24‑hour Change: –70.13 % since the end of last month
- 200‑Day Simple Moving Average: USD 9.28
- 52‑Week High: USD 27.15 (24 November 2025)
- 52‑Week Low: USD 0.19 (19 October 2026)
Peer Performance (Last 24 h)
| Company | Ticker | 24‑hour Change | Current Price | Market Cap | Notes |
|---|---|---|---|---|---|
| Icecure Medical | ICCM | +1.89 % | USD 1.05 | USD 4.9 million | — |
| Eocene | EOCN | +6.02 % | USD 3.07 | USD 3 million | — |
| Tat | TATT.TA | –99.67 % | ILA 32.78 | ILA 1.3 billion | P/E 0.07 |
| Redhill Biopharma | RDHL | +4.37 % | USD 0.49 | USD 2.9 million | — |
| G Willi‑food | WILC.TA | –1 % | ILA 7,799 | ILA 1.1 billion | P/E 19.46 |
Company Overview
Enlivex Therapeutics Ltd. is a clinical‑stage biopharmaceutical company listed on the Nasdaq stock exchange. The firm focuses on developing allogeneic drug candidates to treat immune hyper‑responses. More information can be found on its website at www.enlivex.com .
End of Report
